Showing results (41-50 of 95) with videos related to
Sort By:
Pageof 10
Investigational New Drugs|March 21, 2007
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclinesChristos Kosmas, Nicolas Tsavaris, Nikolaos Malamos, et al.The British Journal of Radiology|March 11, 2017
Imaging of musculoskeletal manifestations in sickle cell disease patientsVijaya Kosaraju, Alok Harwani, Sasan Partovi, et al.Haematologica|March 26, 2003
Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literatureNiki Stavroyianni, Chrysoula Belessi, Kostas Stamatopoulos, et al.Journal of Cancer Research and Clinical Oncology|July 20, 2007
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective studyChristos Kosmas, Manolis S Kallistratos, Petros Kopterides, et al.The Journal of Bone and Joint Surgery. American Volume|March 1, 2021
The Natural History of Benign Bone Tumors of the Extremities in Asymptomatic Children: A Longitudinal Radiographic StudyChristopher D Collier, Grant B Nelson, Keegan T Conry, et al.International Journal of Clinical and Experimental Medicine|April 23, 2014
Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trialsSasan Partovi, Andres A Kohan, Lisa Zipp, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 10, 2002
Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancerNicolas Tsavaris, Christos Kosmas, Kostas Gennatas, et al.Oncology Reports|September 14, 2006
Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastasesNicolas Tsavaris, Petros Kopterides, Christos Kosmas, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 19, 2002
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patientsNicolas Tsavaris, Christos Kosmas, Maria Vadiaka, et al.Scandinavian Journal of Infectious Diseases|August 19, 2007
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanateNikolaos V Sipsas, Christos Kosmas, Panayiotis D Ziakas, et al.Pageof 10